Rebecca McCullough
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Diseases, Alcoholic | 17 | 2026 | 98 | 4.710 |
Why?
| | Ethanol | 24 | 2026 | 631 | 3.920 |
Why?
| | Receptor, Anaphylatoxin C5a | 3 | 2026 | 35 | 1.950 |
Why?
| | Chemical and Drug Induced Liver Injury | 2 | 2024 | 138 | 1.440 |
Why?
| | Liver | 18 | 2026 | 1899 | 1.400 |
Why?
| | Hepatocytes | 6 | 2022 | 224 | 1.250 |
Why?
| | Inflammation | 10 | 2026 | 2884 | 1.160 |
Why?
| | Carbon Tetrachloride | 2 | 2025 | 13 | 0.920 |
Why?
| | Mice, Inbred C57BL | 23 | 2026 | 5993 | 0.910 |
Why?
| | Receptors, Complement | 1 | 2026 | 123 | 0.910 |
Why?
| | Wnt-5a Protein | 1 | 2024 | 25 | 0.860 |
Why?
| | Wnt3A Protein | 1 | 2024 | 11 | 0.860 |
Why?
| | Hepatic Stellate Cells | 1 | 2024 | 14 | 0.860 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 166 | 0.800 |
Why?
| | Binge Drinking | 1 | 2023 | 45 | 0.770 |
Why?
| | Aldehydes | 6 | 2014 | 140 | 0.730 |
Why?
| | Alcoholism | 4 | 2024 | 826 | 0.710 |
Why?
| | Mice | 30 | 2026 | 18356 | 0.700 |
Why?
| | Neurodegenerative Diseases | 1 | 2023 | 143 | 0.690 |
Why?
| | NF-kappa B | 1 | 2025 | 667 | 0.670 |
Why?
| | Fatty Acids | 3 | 2022 | 457 | 0.640 |
Why?
| | Alcohol Drinking | 5 | 2026 | 843 | 0.570 |
Why?
| | Nanoparticles | 1 | 2025 | 517 | 0.570 |
Why?
| | Animals | 35 | 2026 | 38102 | 0.540 |
Why?
| | Aging | 3 | 2025 | 1973 | 0.530 |
Why?
| | Fatty Liver | 4 | 2026 | 253 | 0.530 |
Why?
| | PTEN Phosphohydrolase | 4 | 2016 | 165 | 0.530 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 468 | 0.520 |
Why?
| | Diet, High-Fat | 5 | 2026 | 266 | 0.500 |
Why?
| | Protein Carbonylation | 5 | 2016 | 57 | 0.490 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2018 | 231 | 0.480 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2016 | 70 | 0.470 |
Why?
| | Lactoylglutathione Lyase | 2 | 2026 | 22 | 0.440 |
Why?
| | Myeloid Cells | 1 | 2016 | 147 | 0.440 |
Why?
| | Adipose Tissue | 1 | 2018 | 645 | 0.410 |
Why?
| | Mice, Knockout | 7 | 2026 | 3130 | 0.390 |
Why?
| | Kupffer Cells | 3 | 2026 | 52 | 0.390 |
Why?
| | Hepatitis, Alcoholic | 2 | 2021 | 16 | 0.340 |
Why?
| | Fatty Acid-Binding Proteins | 3 | 2013 | 79 | 0.340 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2016 | 440 | 0.330 |
Why?
| | Fatty Liver, Alcoholic | 2 | 2016 | 14 | 0.320 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2014 | 192 | 0.270 |
Why?
| | Disease Models, Animal | 9 | 2026 | 4568 | 0.270 |
Why?
| | Lipid Peroxidation | 3 | 2014 | 168 | 0.250 |
Why?
| | Myelopoiesis | 1 | 2026 | 10 | 0.240 |
Why?
| | Osteoclasts | 1 | 2026 | 54 | 0.230 |
Why?
| | Public Opinion | 2 | 2023 | 62 | 0.230 |
Why?
| | Liver Cirrhosis | 2 | 2025 | 288 | 0.230 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2020 | 265 | 0.220 |
Why?
| | Proteins | 2 | 2012 | 1023 | 0.220 |
Why?
| | Apoptosis | 4 | 2018 | 2444 | 0.220 |
Why?
| | Gastrointestinal Microbiome | 2 | 2025 | 768 | 0.220 |
Why?
| | Immunologic Surveillance | 1 | 2025 | 25 | 0.220 |
Why?
| | Cell Transdifferentiation | 1 | 2024 | 31 | 0.210 |
Why?
| | Liver Regeneration | 1 | 2024 | 46 | 0.210 |
Why?
| | Immunity | 1 | 2025 | 140 | 0.210 |
Why?
| | Osteogenesis | 1 | 2026 | 204 | 0.200 |
Why?
| | Inflammasomes | 1 | 2025 | 144 | 0.200 |
Why?
| | Ethyl Ethers | 1 | 2022 | 5 | 0.190 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2023 | 30 | 0.190 |
Why?
| | Wnt Signaling Pathway | 1 | 2024 | 212 | 0.190 |
Why?
| | Macrophages | 3 | 2026 | 1507 | 0.180 |
Why?
| | beta Catenin | 1 | 2024 | 254 | 0.180 |
Why?
| | Microglia | 1 | 2025 | 273 | 0.180 |
Why?
| | Glycoproteins | 2 | 2021 | 354 | 0.180 |
Why?
| | Immune Tolerance | 1 | 2025 | 385 | 0.180 |
Why?
| | Central Nervous System Depressants | 2 | 2018 | 84 | 0.180 |
Why?
| | Male | 22 | 2026 | 73011 | 0.180 |
Why?
| | Complement Factor D | 2 | 2020 | 28 | 0.180 |
Why?
| | Cytokines | 3 | 2018 | 2069 | 0.170 |
Why?
| | Proteomics | 4 | 2021 | 1188 | 0.170 |
Why?
| | Fluorocarbons | 1 | 2023 | 120 | 0.170 |
Why?
| | Oxidative Stress | 6 | 2016 | 1360 | 0.170 |
Why?
| | Glucose | 1 | 2026 | 1049 | 0.170 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2025 | 373 | 0.160 |
Why?
| | Protein Phosphatase 2 | 1 | 2021 | 41 | 0.160 |
Why?
| | Mitochondria, Liver | 1 | 2011 | 70 | 0.160 |
Why?
| | Endoplasmic Reticulum | 2 | 2014 | 264 | 0.160 |
Why?
| | Sirtuin 3 | 1 | 2011 | 60 | 0.160 |
Why?
| | Extracellular Matrix | 1 | 2024 | 563 | 0.160 |
Why?
| | Multigene Family | 1 | 2011 | 210 | 0.160 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 138 | 0.160 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 119 | 0.150 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 63 | 0.150 |
Why?
| | Sarcopenia | 1 | 2021 | 91 | 0.150 |
Why?
| | Humans | 25 | 2026 | 145783 | 0.150 |
Why?
| | Female | 12 | 2025 | 79045 | 0.150 |
Why?
| | Hippocampus | 1 | 2025 | 973 | 0.150 |
Why?
| | Sulfhydryl Compounds | 1 | 2011 | 189 | 0.140 |
Why?
| | Intestinal Mucosa | 2 | 2025 | 675 | 0.140 |
Why?
| | Models, Molecular | 4 | 2014 | 1599 | 0.140 |
Why?
| | Anaphylatoxins | 1 | 2018 | 1 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 4 | 2021 | 572 | 0.140 |
Why?
| | Blotting, Western | 2 | 2016 | 1184 | 0.140 |
Why?
| | Premature Birth | 1 | 2023 | 390 | 0.140 |
Why?
| | Endothelial Cells | 1 | 2025 | 878 | 0.140 |
Why?
| | Histones | 1 | 2024 | 666 | 0.140 |
Why?
| | Adipokines | 1 | 2018 | 57 | 0.140 |
Why?
| | Liver Neoplasms | 1 | 2025 | 777 | 0.140 |
Why?
| | Primary Cell Culture | 1 | 2018 | 172 | 0.130 |
Why?
| | Gastrointestinal Tract | 1 | 2020 | 204 | 0.130 |
Why?
| | Protective Agents | 1 | 2018 | 42 | 0.130 |
Why?
| | Rats | 4 | 2017 | 5585 | 0.130 |
Why?
| | Complement Pathway, Alternative | 1 | 2018 | 121 | 0.130 |
Why?
| | Evolution, Molecular | 1 | 2011 | 494 | 0.130 |
Why?
| | Phosphorylation | 2 | 2016 | 1708 | 0.120 |
Why?
| | Adipocytes | 1 | 2018 | 223 | 0.120 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2016 | 14 | 0.120 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2016 | 24 | 0.120 |
Why?
| | Immune System | 1 | 2018 | 180 | 0.120 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 11 | 0.120 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1723 | 0.120 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2023 | 655 | 0.120 |
Why?
| | Complement C1q | 1 | 2016 | 32 | 0.120 |
Why?
| | Blood Glucose | 1 | 2026 | 2344 | 0.120 |
Why?
| | Extracellular Vesicles | 1 | 2018 | 171 | 0.120 |
Why?
| | Amino Acid Sequence | 4 | 2014 | 2131 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 1 | 2017 | 276 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 337 | 0.110 |
Why?
| | Rats, Wistar | 1 | 2016 | 450 | 0.110 |
Why?
| | Immunoglobulin M | 1 | 2016 | 265 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 457 | 0.110 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 139 | 0.100 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 159 | 0.100 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 118 | 0.100 |
Why?
| | Complement Activation | 1 | 2016 | 399 | 0.090 |
Why?
| | Lipopolysaccharides | 1 | 2016 | 858 | 0.090 |
Why?
| | Molecular Sequence Data | 3 | 2011 | 2883 | 0.090 |
Why?
| | Connective Tissue Diseases | 1 | 2012 | 85 | 0.090 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2014 | 154 | 0.090 |
Why?
| | Heart Valve Diseases | 1 | 2012 | 151 | 0.080 |
Why?
| | MicroRNAs | 1 | 2017 | 686 | 0.080 |
Why?
| | Aortic Valve Stenosis | 1 | 2014 | 256 | 0.080 |
Why?
| | Dietary Fats | 1 | 2013 | 308 | 0.080 |
Why?
| | Enzyme Activation | 2 | 2013 | 762 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2017 | 2601 | 0.080 |
Why?
| | Chromatography, Liquid | 2 | 2013 | 450 | 0.080 |
Why?
| | Protein Conformation | 1 | 2012 | 938 | 0.070 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2012 | 110 | 0.060 |
Why?
| | Immunoprecipitation | 2 | 2021 | 149 | 0.060 |
Why?
| | Homeostasis | 2 | 2021 | 644 | 0.060 |
Why?
| | DNA Primers | 2 | 2012 | 505 | 0.060 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 855 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2011 | 2525 | 0.060 |
Why?
| | Diethylnitrosamine | 1 | 2025 | 6 | 0.060 |
Why?
| | Biomarkers | 3 | 2021 | 4302 | 0.060 |
Why?
| | Signal Transduction | 4 | 2017 | 5224 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2023 | 4151 | 0.050 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2014 | 49 | 0.050 |
Why?
| | Hep G2 Cells | 1 | 2014 | 73 | 0.050 |
Why?
| | Alanine Transaminase | 2 | 2016 | 151 | 0.050 |
Why?
| | Hawaii | 1 | 2023 | 37 | 0.050 |
Why?
| | Lipid Metabolism | 1 | 2026 | 529 | 0.050 |
Why?
| | Models, Chemical | 1 | 2014 | 250 | 0.050 |
Why?
| | Dehydroepiandrosterone | 1 | 2023 | 49 | 0.050 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2012 | 29 | 0.050 |
Why?
| | Hematopoietic Stem Cells | 1 | 2026 | 435 | 0.050 |
Why?
| | Malondialdehyde | 1 | 2012 | 31 | 0.050 |
Why?
| | Acrolein | 1 | 2012 | 22 | 0.050 |
Why?
| | Heme | 1 | 2023 | 90 | 0.040 |
Why?
| | Triglycerides | 2 | 2016 | 520 | 0.040 |
Why?
| | Lactic Acid | 1 | 2024 | 295 | 0.040 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 2023 | 93 | 0.040 |
Why?
| | Tretinoin | 1 | 2023 | 125 | 0.040 |
Why?
| | Glycolysis | 1 | 2024 | 340 | 0.040 |
Why?
| | Eye Proteins | 1 | 2021 | 92 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 592 | 0.040 |
Why?
| | Complement C2 | 1 | 2020 | 8 | 0.040 |
Why?
| | Microsomes, Liver | 1 | 2011 | 85 | 0.040 |
Why?
| | Complement C5 | 1 | 2020 | 33 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2025 | 1133 | 0.040 |
Why?
| | Complement C4 | 1 | 2020 | 26 | 0.040 |
Why?
| | Intercellular Junctions | 1 | 2020 | 35 | 0.040 |
Why?
| | NAD | 1 | 2011 | 79 | 0.040 |
Why?
| | Myoblasts | 1 | 2021 | 83 | 0.040 |
Why?
| | Glycosylation | 1 | 2011 | 173 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 27 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2011 | 362 | 0.040 |
Why?
| | Acetylation | 1 | 2011 | 259 | 0.040 |
Why?
| | Iron | 1 | 2023 | 359 | 0.040 |
Why?
| | Permeability | 1 | 2020 | 169 | 0.040 |
Why?
| | Boston | 1 | 2020 | 93 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 319 | 0.040 |
Why?
| | Complement Factor B | 1 | 2020 | 106 | 0.040 |
Why?
| | Organ Specificity | 1 | 2020 | 309 | 0.040 |
Why?
| | Pregnancy | 2 | 2023 | 7216 | 0.040 |
Why?
| | Species Specificity | 1 | 2011 | 546 | 0.040 |
Why?
| | Chromatin | 1 | 2024 | 553 | 0.040 |
Why?
| | Complement C3 | 1 | 2020 | 187 | 0.040 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 179 | 0.040 |
Why?
| | Birth Weight | 1 | 2023 | 517 | 0.040 |
Why?
| | Water | 1 | 2023 | 448 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2021 | 499 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2011 | 239 | 0.040 |
Why?
| | Congresses as Topic | 1 | 2020 | 224 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 923 | 0.030 |
Why?
| | Genome, Human | 1 | 2011 | 422 | 0.030 |
Why?
| | Cell Movement | 1 | 2023 | 963 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 322 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1043 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2011 | 1368 | 0.030 |
Why?
| | Base Sequence | 1 | 2011 | 2171 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2011 | 327 | 0.030 |
Why?
| | Complement System Proteins | 1 | 2020 | 314 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 693 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 361 | 0.030 |
Why?
| | Protein Binding | 2 | 2014 | 2240 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 523 | 0.030 |
Why?
| | Complement C1 Inactivator Proteins | 1 | 2016 | 6 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 2023 | 956 | 0.030 |
Why?
| | Complement C1 Inhibitor Protein | 1 | 2016 | 12 | 0.030 |
Why?
| | Lipogenesis | 1 | 2016 | 62 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 96 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 365 | 0.030 |
Why?
| | Solubility | 1 | 2016 | 240 | 0.030 |
Why?
| | Hyaluronic Acid | 1 | 2017 | 226 | 0.030 |
Why?
| | Cell Death | 1 | 2016 | 382 | 0.030 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 4 | 0.030 |
Why?
| | CD36 Antigens | 1 | 2014 | 32 | 0.030 |
Why?
| | Glutathione | 1 | 2016 | 370 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 58 | 0.030 |
Why?
| | Echocardiography, Transesophageal | 1 | 2014 | 132 | 0.020 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2013 | 32 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 26 | 0.020 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 56 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3551 | 0.020 |
Why?
| | Age Factors | 1 | 2020 | 3346 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3634 | 0.020 |
Why?
| | Protein Folding | 1 | 2014 | 277 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2017 | 1217 | 0.020 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 2012 | 10 | 0.020 |
Why?
| | Coronary Artery Bypass | 1 | 2014 | 268 | 0.020 |
Why?
| | Organ Size | 1 | 2013 | 461 | 0.020 |
Why?
| | Ubiquitination | 1 | 2012 | 119 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4330 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2018 | 835 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2012 | 538 | 0.020 |
Why?
| | Adiponectin | 1 | 2013 | 242 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 408 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 979 | 0.020 |
Why?
| | Patient Selection | 1 | 2014 | 739 | 0.020 |
Why?
| | Computer Simulation | 1 | 2014 | 1003 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2014 | 1038 | 0.020 |
Why?
| | Survival Rate | 1 | 2014 | 2094 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2012 | 732 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2013 | 740 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 707 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2191 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 2012 | 611 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2805 | 0.010 |
Why?
| | Middle Aged | 2 | 2020 | 36309 | 0.010 |
Why?
| | Transcription Factors | 1 | 2013 | 1736 | 0.010 |
Why?
| | Risk Assessment | 1 | 2014 | 3752 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2399 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 7134 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2014 | 8347 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2014 | 2977 | 0.010 |
Why?
| | Prospective Studies | 1 | 2012 | 8078 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2014 | 11794 | 0.010 |
Why?
| | Risk Factors | 1 | 2012 | 10919 | 0.010 |
Why?
| | Adult | 1 | 2020 | 40881 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 17330 | 0.010 |
Why?
|
|
McCullough's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|